SHIRE PLC: Director Declaration
November 15, 2012 - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that, in accordance with Listing Rule LR 9.6.14, its non-executive director, Anne Minto, has been appointed as a Non-Executive Director to the Board of Directors of Tate & Lyle PLC, with effect from December 1, 2012.
Tony Guthrie Deputy Company Secretary
For further information please contact:
Eric Rojas email@example.com +1 781 482 0999
Sarah Elton-Farr firstname.lastname@example.org +44 1256 894157
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Through our deep understanding of patients' needs, we develop and provide healthcare in the areas of:
* Behavioral Health and Gastro Intestinal conditions
* Rare Diseases * Regenerative Medicine as well as other symptomatic conditions treated by specialist physicians. We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders. Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX Press Release
-0- Nov/15/2012 16:30 GMT